PAF projection in patients with clinical indications The attributable fraction of carcinogenic drugs to cancer incidence and death in patients with clinical indications of group I carcinogenic drugs showed an increasing trend from 2015 to 2030 ( Table 4 ).
← all excerpts
Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030.
1
—
—